InsiderPulse
Dashboard

ELV

Elevance Health, Inc.

Health CareS&P 500

Elevance Health, Inc. insider trading

Elevance Health, Inc. files with the SEC as a Hospital & Medical Service Plans company headquartered in Indianapolis, IN. Every time one of its executives or directors buys or sells the stock, the filing appears here the moment it reaches the SEC — with grants and option exercises set apart from the trades that cost the insider their own money.

From SEC filings

Recent ELV insider transactions

7 insiders traded ELV on the open market between Mar 05, 2026 and Jul 17, 2026 — 4 purchases worth $2.2M, 5 sales worth $1.7M.

Bought
$2.2M
Sold
$1.7M

none on a 10b5-1 plan

Net
+$493.1K
Insiders
7

Open-market purchases (code P) and sales (code S) from Elevance Health, Inc.'s own SEC Form 4 filings. Grants and option exercises are excluded — they are compensation, not decisions. Share counts are derived from the reported value and price. Verify any figure against the original filing before acting on it; this is monitoring, not advice.

Filing history last read from EDGAR on Sep 20, 2026. The live dashboard shows new filings the moment they clear.

Every ELV Form 4 on SEC.gov

SEC Form 4 data, Q3 2024 to Q2 2026

ELV insider trading by quarter

Between Jul 01, 2024 and Jun 30, 2026, 9 insiders traded ELV on the open market: 5 purchases worth $3.7M and 17 sales worth $26.1M, 7 of the sales pre-scheduled under a 10b5-1 plan. In the last four quarters alone: 5 purchases ($3.7M) and 5 sales ($1.7M), by 7 insiders.

QuarterBoughtSold
Q2 2026—−$826.6K3 sales
Q1 2026+$869.5K1 buy−$918.1K2 sales
Q4 2025——
Q3 2025+$2.8M4 buys—
Q2 2025—−$1.9M1 sale
Q1 2025—−$1.6M2 sales
Q4 2024—−$3.2M1 sale
Q3 2024—−$17.6M8 sales · 7 on a plan
Largest purchase
+$1.5M of ELV by Boudreaux Gail (President and CEO · Director) on Jul 18, 2025.
Largest sale
−$10.4M of ELV by Boudreaux Gail (President and CEO · Director) on Jul 22, 2024, under a 10b5-1 plan.

Open-market transactions through Jun 30, 2026most recent first

  • DeVore Susan D.

    Director

    +$374.6K

    Aug 19, 2025

    1,200 sh · $312.15

  • Boudreaux Gail

    President and CEO · Director

    +$1.5M

    Jul 18, 2025

    5,116 sh · $287.12

  • Boudreaux Gail

    President and CEO · Director

    +$667.7K

    Jul 18, 2025

    2,334 sh · $286.07

  • Boudreaux Gail

    President and CEO · Director

    +$302.4K

    Jul 18, 2025

    1,050 sh · $287.96

  • Kaye Mark

    EVP & CFO

    −$1.9M

    Apr 24, 2025

    4,588 sh · $424.82

  • Penczek Ronald W

    CAO & Controller

    −$183.9K

    Mar 10, 2025

    443 sh · $415.13

  • Kendrick Charles Morgan JR

    EVP & President, Commercial

    −$1.4M

    Mar 05, 2025

    3,504 sh · $396.30

  • Kendrick Charles Morgan JR

    EVP & President, Commercial

    −$3.2M

    Oct 18, 2024

    7,417 sh · $432.14

  • Peru Ramiro G10b5-1

    Director

    −$400.2K

    Aug 05, 2024

    753 sh · $531.52

  • Boudreaux Gail10b5-1

    President and CEO · Director

    −$10.4M

    Jul 22, 2024

    20,779 sh · $500.36

  • Boudreaux Gail10b5-1

    President and CEO · Director

    −$3.3M

    Jul 22, 2024

    6,621 sh · $501.40

  • Boudreaux Gail10b5-1

    President and CEO · Director

    −$1.1M

    Jul 22, 2024

    2,250 sh · $504.27

  • Boudreaux Gail10b5-1

    President and CEO · Director

    −$1.1M

    Jul 22, 2024

    2,250 sh · $502.23

  • Boudreaux Gail10b5-1

    President and CEO · Director

    −$548.4K

    Jul 22, 2024

    1,100 sh · $498.50

  • Boudreaux Gail10b5-1

    President and CEO · Director

    −$503.7K

    Jul 22, 2024

    1,000 sh · $503.67

From SEC's quarterly Form 3, 4 and 5 data sets: code P purchases and code S sales of common stock, by the date the trade happened. Where a fund and the people who control it each report the same block, it is counted once. Trades made in the last days of Q2 2026 but filed after it closed arrive with SEC's next quarterly release.

Elevance Health, Inc. company record

SEC industry classification
Hospital & Medical Service Plans
Headquarters
Indianapolis, IN
Incorporated in
IN
Listed on
NYSE
SEC Central Index Key
0001156039
Previously filed as
Anthem, Inc.

Sourced from this company's own SEC submissions record. The industry label is SEC's Standard Industrial Classification, which is more specific than the Health Care sector shown above.

After insiders bought ELV

What the stock actually did in the 90 days following each open-market purchase

Don't check ELV — let it ping you

Get told the moment an insider moves on ELV

Pro watches Elevance Health, Inc. for you and sends a Telegram ping within moments of a Form 4 clearing EDGAR — a C-suite open-market buy, a cluster, a 10b5-1 regime break — long before it reaches the press. Add ELV to a watchlist, see each mover's benchmark-measured track record and which legendary funds hold it, and read the full filing history instead of the last 72 hours.

Track ELV on the live dashboardFilings on SEC.gov

The live dashboard is free to open. Alerts, watchlists, full filing history and each mover's benchmark-measured track record are Pro. Monitoring, not advice.

How to read ELV insider activity

Open-market purchase (code P)
An insider spending their own money at market price. This is the only buy code that reliably carries signal — it is a decision, not compensation.
Grants and option exercises (codes A, M)
Scheduled compensation. Most "insider buying" headlines are really this, which is why InsiderPulse weights it at a fraction of a real purchase.
Cluster buy
Two or more different insiders buying on the open market in the same window. One executive buying can mean anything; three is much harder to explain away.

Other Health Care tickers

HCAZTSMRNABIIBILMNIDXXIQVAWSTRMDDXCMALGN
This week on the tape: who actually chose to sellThe weekly split of scheduled 10b5-1 selling vs deliberate sales, with the deciders named.

Questions

Are ELV insiders buying or selling?
Between Mar 05, 2026 and Jul 17, 2026, 7 Elevance Health, Inc. insiders made 4 open-market purchases worth $2.2M and 5 sales worth $1.7M, a net purchase of $493.1K.
How much ELV stock have insiders bought and sold in the last two years?
Between Jul 01, 2024 and Jun 30, 2026, 9 Elevance Health, Inc. insiders made 5 open-market purchases worth $3.7M and 17 sales worth $26.1M. 7 of the sales were pre-scheduled under a Rule 10b5-1 plan. In the four quarters to Jun 30, 2026: 5 purchases ($3.7M) and 5 sales ($1.7M). The largest purchase was Boudreaux Gail buying $1.5M on Jul 18, 2025. The largest sale was Boudreaux Gail selling $10.4M on Jul 22, 2024.
What was the largest recent ELV insider trade?
Kendrick Charles Morgan JR (EVP & President, Commercial) sold $910.6K of ELV stock on Mar 06, 2026 at about $284.92 a share.
When did an insider last buy ELV shares?
The most recent open-market purchase on file is Peru Ramiro G (Director) buying $366.1K on Jul 17, 2026. The largest purchase in the period was $869.5K by Collis Steven H.
Where does ELV insider trading data come from?
From the Form 4 filings Elevance Health, Inc.'s officers, directors and 10% owners must send the SEC within two business days of a trade. Each row on this page links to its original filing on SEC EDGAR. Share grants and option exercises are kept apart from open-market purchases and sales, because only the latter cost the insider their own money.

Get the free Insider Brief

Each weekday evening: the day's biggest open-market insider buys, cluster formations and 10b5-1 plan breaks — in plain English, with grants and routine vesting stripped out. Honest about what the data can and cannot say.

No account needed. One-click unsubscribe.